Beroni Group Limited Approval for R&D Rebate for Anti-Cancer Drug PENAO

Sydney, Australia (ABN Newswire) - Beroni Group (OTCMKTS:BNIGF) (NSX:BTG), an Australia-based biopharmaceutical enterprise, today announced that PENAO Pty Ltd, its majority-owned, Sydney-based anti-cancer drug development company, has been approved by the Australian government for the annual 43.5% R&D rebate of eligible expenditure.

The approval also includes R&D overseas activities so long as the total overseas expenditure claim over the life of the R&D activities is less than the expected total expenditure on the Australian R&D activities to which they are scientifically linked.

The PENAO drug manufacture is expected to complete in the first half of 2022. Raw materials have been procured, familiarization studies have been completed and optimization work is progressing well at Aurigene Pharmaceutical Services Ltd, India.

"Aurigene is delighted to partner with PENAO Pty Ltd. In the past 18 years of our work, a key therapy area has been anticancer drug discovery and clinical development. Our technical and infrastructure capabilities provide an integrated drug substance and drug product program for PENAO." said Ravi Venkataramanan, CEO of Aurigene Pharmaceutical Services Ltd, a wholly-owned subsidiary of Dr. Reddy's Laboratories Limited (BOM:500124) (NYSE:RDY).

"We are pleased to receive the Australian government's support for our R&D activities, and we hope that the annual rebate signals to investors the rigorous due diligence conducted by the Australian government and our commitment to develop the PENAO drug to potentially meet the unmet medical need of millions of cancer patients worldwide" said Jacky Zhang, CEO of Beroni Group.



About Beroni Group Limited:  

Beroni Group (NSX:BTG) (OTCMKTS:BNIGF) is an international biopharmaceutical enterprise dedicated to the innovation and commercialization of drugs and therapies to combat various global diseases such as cancer and infectious diseases. Its diversified portfolio is comprised of a US FDA approved virus diagnostic kit, an e-commerce platform for the sale of pharmaceutical products and a development pipeline targeting oncology and cell therapies. Beroni has operations in Australia, United States, China and Japan. To learn more about Beroni, please visit www.beronigroup.com.



Source:
Beroni Group Limited



Contact:
Dragon Gate Investment Partners LLC
Tel: +1(646)-801-2803
Email: BNIGF@dgipl.com

News Provided by ABN Newswire via QuoteMedia

The Conversation (0)
US flag, Congress building.

Top Stories This Week: Gold Price Drops, Then Bounces on Trump Victory, Fed Rate Cut

The gold price faced both ups and downs this week as two key events impacted the industry.

The period began on a strong note for the yellow metal, which was steady at around the US$2,740 per ounce level on Monday (November 4) and Tuesday (November 5). However, Donald Trump's victory against Kamala Harris at the polls had a negative effect on gold — it sank to just under US$2,650 on Wednesday (November 6).

What factors drove that decline in gold? John Feneck of Feneck Consulting said in an interview that the drop was a knee-jerk reaction to the election outcome. Here's how he explained it:

Keep reading...Show less
Leigh Goehring, copper bars.

Leigh Goehring: Gold's "Massive Bull Market" Just Starting; Uranium and Copper Outlook

Leigh Goehring, managing partner at Goehring & Rozencwajg, shared his outlook for gold, outlining calculations that show the yellow metal potentially rising to the US$15,000 to US$25,000 per ounce range in this cycle.

"We're a believer that we have just entered into a massive bull market in gold, and the underlying fundamental reasons are the fact that over the last 15 years, ever since the global financial crisis, we've printed so much money," he said.

Goehring said that in a May 2000 interview with Forbes Magazine, he predicted the yellow metal could rise as high as US$2,500 — a call that was considered "outrageous" given gold's price of US$250 at the time.

Keep reading...Show less
Flynn Gold

Significant Exploration Target for Golden Ridge, NE Tasmania

Flynn Gold Limited (ASX: FG1, “Flynn” or “the Company”) is pleased to announce a maiden JORC compliant Exploration Target for the Trafalgar, Brilliant and Link Zone prospects at its 100%-owned Golden Ridge Project in North-east Tasmania.

Keep reading...Show less
Gold letters spelling "Fed" in front of a pile of gold dollar coins and US flag.

Fed Cuts Rate in Post-Election Meeting, Gold and Silver Gain

Hot on the heels of Donald Trump’s victory in the US presidential election was an important meeting of the US Federal Reserve’s Federal Open Markets Committee (FOMC) on November 6 and 7.

At the meeting, the committee decided to lower the benchmark rate by 25 basis points to 4.5 to 4.75 percent. This marks the second cut by the FOMC, which made an outsized 50 point cut at its last meeting in September.

The rate cuts have come as inflation has cooled towards the 2 percent target set by the Fed when it first began raising interest rates in February 2022. While the personal consumption expenditure index for September had fallen to an overall 2.1 percent increase year-over-year, the committee was still concerned about some stickiness, as the PCE less food and energy prices was up 2.7 percent.

Keep reading...Show less

Newmont Files Early Warning Report

Newmont Corporation (NYSE: NEM, TSX: NGT, ASX: NEM, PNGX: NEM) (together with its affiliates, " Newmont " or the " Company ") announced today that Newcrest Canada Holdings Inc. (the " Vendor "), a wholly-owned subsidiary of Newmont, sold all 14,674,056 common shares of Azucar Minerals Ltd. (" Azucar ") held by the Vendor to Almadex Minerals Ltd. (" Almadex ") and certain directors and officers of Azucar (collectively with Almadex, the " Purchasers "), for an aggregate purchase price of $220,110.84, being $0.015 per share (the " Transaction "). The Transaction was completed pursuant to a share purchase agreement among the Vendor and the Purchasers dated as of October 21, 2024 (the " Share Purchase Agreement ").

News Provided by Business Wire via QuoteMedia

Keep reading...Show less

Wheaton Precious Metals Announces Third Quarter 2024 Results and Record Quarterly Operating Cash Flow

Designated News Release
THIRD QUARTER FINANCIAL RESULTS

"Wheaton achieved record cash flow from operations in the third quarter of 2024, underscoring the effectiveness of our business model in leveraging rising commodity prices, with our cash operating margins increasing by over 30% relative to the third quarter of 2023. Our portfolio of operating assets delivered solid production levels, continuing to support our annual production guidance range for 2024 of 550,000 to 620,000 gold equivalent ounces," said Randy Smallwood, President and CEO of Wheaton Precious Metals. "Shortly following the quarter, Wheaton announced two accretive, precious metals streaming agreements, including a new stream on Montage's Koné Project and an amendment to the existing stream on Rio2's Fenix Project. Together, these transactions further diversify our strategic partnerships and the geography of our portfolio. Once ramped-up, the Koné Project is forecast to contribute meaningful near-term production, reinforcing Wheaton's already prominent position as a leader in the sector's growth landscape."

News Provided by Canada Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×